Public trial registry of the CCC-Munich

Trial C-PRECISE-01

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
C-PRECISE-01
World
Full title
:

Open-label, Multicentre, Phase Ib/II Study of MEN1611, a PI3K Inhibitor, and Cetuximab in Patients with PIK3CA Mutated Metastatic Colorectal Cancer Failing Irinotecan, Oxaliplatin, 5-FU and Anti-EGFR Containing Regimens

World
Responsible organization
:
NULL
Indications
Classification Code Description
- - Other trials
Trial design
World
Phase
:
I/II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo - Therapieart: andere

Participants
Function Prename Surname Organization
World Responsible contact Sylvie Lorenzen NULL Magnifier